Brand:Avene
At Chemist Warehouse In stock
Same price since 12 Nov
Tracking since 8 Nov
We may earn a commission at no cost to you. How it works
Tracking since 8 Nov · 11 days
Avène Tolerance Control Intensive Skin Recovery Serum is a concentrated recovery serum that instantly soothes sensitive skin*.
*In-use tolerance study under dermatological and ophthalmological controls and efficacy assessment on 35 subjects product applied twice daily for 21 days.
Avène Tolerance Control Intensive Skin Recovery Serum is a concentrated recovery serum that instantly soothes sensitive skin*. It helps restore the skin barrier** and reduce skin sensitivity*, thanks to Avène Thermal Spring Water and Pro-Vitamin B5.
*In-use tolerance study under dermatological and ophthalmological controls and efficacy assessment on 35 subjects product applied twice daily for 21 days.
**In a dry skin context - Evaluation of tolerance repair serum on skin barrier repair of sensitized epidermis after dehydration stress The confidence of healthy skin
Suitable For: 18-54
Product Claims: Avène Tolerance Control Intensive Skin Recovery Serum is a concentrated recovery serum that instantly soothes sensitive skin*. It helps restore the skin barrier** and reduce skin sensitivity*, thanks to Avène Thermal Spring Water and Pro-Vitamin B5. *In-use tolerance study under dermatological and ophthalmological controls and efficacy assessment on 35 subjects product applied twice daily for 21 days. **In a dry skin context - Evaluation of tolerance repair serum on skin barrier repair of sensitized epidermis after dehydration stress
Size: 30ml
KEY FEATURES
• Instantly calms skin*. *In-use tolerance study under dermatological and ophthalmological controls and efficacy assessment on 35 subjects product applied twice daily for 21 days.
• Immediately soothes tightness and tingling*. *In-use tolerance study under dermatological and ophthalmological controls and efficacy assessment on 35 subjects product applied twice daily for 21 days.
• Reduces tightness in 60 seconds***. ***Clinical Study Report - In-use tolerance study under dermatological and ophthalmological controls and efficacy assessment. Version n° 1 - Date: 21/04/2022